SIRC: Replica results at the 24th National Congress
Professor Li Volti talked about the Replica project results with a presentation titled "The impact of cigarette smoke and reduced risk products aerosol on endothelial function: the REPLICA project"
Professor Li Volti talked about the Replica project results with a presentation titled "The impact of cigarette smoke and reduced risk products aerosol on endothelial function: the REPLICA project"
At 11.15 am, October 19, prof. Polosa will host remotely the panel Longer Term Outcomes of Cessation and Harm Reduction with a presentation on "Changes in Health Symptoms - Results and Analysis Methodologies".
“𝑊𝑒 𝑛𝑒𝑒𝑑 𝑡𝑜 𝑐𝑜𝑙𝑙𝑎𝑏𝑜𝑟𝑎𝑡𝑒 𝑡𝑜𝑔𝑒𝑡ℎ𝑒𝑟 𝑠𝑜 𝑡ℎ𝑎𝑡 𝑒𝑣𝑒𝑟𝑦 𝑠𝑖𝑛𝑔𝑙𝑒 𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑏𝑒𝑐𝑜𝑚𝑒𝑠 𝑎𝑛 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑡𝑜𝑜𝑙. 𝑊𝑒 𝑑𝑜𝑛'𝑡 𝑤𝑎𝑛𝑡 𝑡𝑜 𝑝𝑢𝑛𝑖𝑠ℎ 𝑎𝑢𝑡ℎ𝑜𝑟𝑠 𝑓𝑜𝑟 𝑡ℎ𝑒𝑖𝑟 𝑗𝑢𝑛𝑘 𝑝𝑎𝑝𝑒𝑟𝑠, 𝑤𝑒 𝑤𝑎𝑛𝑡 𝑡𝑜 𝑝𝑟𝑜𝑣𝑖𝑑𝑒 𝑡ℎ𝑒 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 𝑡𝑜 𝑖𝑚𝑝𝑟𝑜𝑣𝑒”
The findings presented by CoEHAR researchers can contribute the discussions of ENDS for cessation and support harm reduction strategies in the world.
The conference will bring together leading experts in the field to discuss the latest research on dyslipidemias and their management. Topics to be covered include the latest guidelines from the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), as well as innovative topics such as environmental risk factors, including smoking, and their role in the progression of atherosclerosis.
The summer graduation session at the University of Catania was held last week. Among the works of the new graduates in the biotechnology degree courses are also two theses on…
CoEHAR interview with prof. Attaullah Ahmadi, visiting researcher della French School of Public Health e Global Health Focus presso il Dipartimento di Medicina Clinica e Sperimentale dell'Università di Catania. https://www.youtube.com/watch?v=MeaAmfnw4WU
“TOBACCO HARM REDUCTION IN AFGHANISTAN: EXPERIENCES, CHALLENGES, AND RECOMMENDATIONS”, new seminar at CoEHAR, University of Catania. On Friday, 14th July 2023 at 12 am CEST, Room 6 in the Biological Tower, Dr.…
The use of the drug combined with an innovative vaping cessation counseling program was safe and effective for quitting e-cigarettes. The combined approach also decreased the chances of relapsing back to vaping and smoking.
During the 2023 edition of the GFN, a pool of international diabetologists, coordinated by CoEHAR, addressed the issue of cigarette smoking among diabetes patients, setting new international treatment guidelines to be published soon.